Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search
Fullscreen

For citation:


Totolyan N.A., Alifirova V.M., Bakhtiyarova K.Z., Boyko A.N., Vlasov Ya.V., Goncharova Z.A., Zakharova M.N., Kasatkin D.S., Kotov S.V., Nilov A.I., Sivertseva S.A., Sokolova A.A., Spirin N.N., Khabirov F.A., Paradnika D. Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(5):138-145. (In Russ.) https://doi.org/10.14412/2074-2711-2020-5-138-145

Views: 464


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)